Since the expression of AHR in MES-GBM is not higher than that in other subtypes, these findings indicate that AHR is one of several mechanisms in GBM that control GAMs recruitment and functions through mediators such as CCL2 and CCR2. The gene discussed is CCL2; the disease is glioblastoma.